NDC 67296-2300-02 - Hyoscyamine Sulfate SL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2300
- Requested NDC
- 67296-2300-02
- Package NDCs from labels
- 67296-2300-1, 67296-2300-2, 67296-2300-02
- Manufacturer
- Redpharm Drug
- Effective date
- 2026-10-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hyoscyamine Sulfate SL - Redpharm Drug | Redpharm Drug | 2026-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 2d5fa637-0696-40fe-9bc1-fcb6f07a50f6 | 2026-11-02 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| OSCIMIN | HYOSCYAMINE SULFATE | Larken Laboratories, Inc. | 8504adad-f6d0-4671-b655-4b62bf29a516 | 2026-11-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2026-10-26 | Warnings, Adverse reactions | F2R8V82B84 |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2026-10-26 | Warnings, Adverse reactions | F2R8V82B84 |
| URIBEL TABS | METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Mission Pharmacal Company | 09821e01-1135-e75c-e063-6294a90a3451 | 2026-10-14 | Warnings | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Redpharm Drug | 584755e4-fea9-4827-e063-6394a90a4a0a | 2026-10-10 | Warnings, Adverse reactions | 67296-2300-1 67296-2300-2 67296-2300 67296230002 1046982 5d766d14-635b-6f08-e063-6394a90a5c27 584755e4-fea9-4827-e063-6394a90a4a0a F2R8V82B84 |
| Uribel Tabs | METHENAMINE, BENZOIC ACID, PHENYL SALICYLATE, METHYLENE BLUE, HYOSCYAMINE SULFATE | Cintex Services, LLC | 5ccadff1-461a-335a-e063-6394a90ad5d7 | 2026-10-05 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Sportpharm LLC | 92b37c97-b6c2-4c44-a39c-22b22e6f427c | 2026-10-02 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | REMEDYREPACK INC. | 24dd83d1-ab57-46f9-b5c0-1b1df4de7d10 | 2026-09-11 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Granulation Technology, Inc. | 57b12b25-adea-c9bc-e063-6394a90aa925 | 2026-07-29 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | REMEDYREPACK INC. | c1c89510-6381-466f-be1a-6b104a335b56 | 2026-06-09 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | 3749da41-19f3-46b2-887d-7f8ae2268700 | 2026-06-08 | Warnings, Adverse reactions | 1046982 F2R8V82B84 |
| Phenohytro | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, AND SCOPOLAMINE HYDROBROMIDE | ATLANTIC BIOLOGICALS CORP. | a5aaf1db-1938-4073-9da4-c47f959d013e | 2026-05-19 | Warnings, Adverse reactions | F2R8V82B84 |
| Digenyx | HYOSCYAMINE SULFATE 0.125 MG | PureTek Corporation | 512f3202-4ecf-1218-e063-6294a90a0544 | 2026-05-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | PD-Rx Pharmaceuticals, Inc. | 51a07955-485f-1357-e063-6394a90ad3f8 | 2026-05-11 | Warnings, Adverse reactions | F2R8V82B84 |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Granulation Technology, Inc. | 4f863ae9-d010-b2f5-e063-6394a90a1a95 | 2026-04-15 | Warnings, Adverse reactions | F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.